SEARCH

SEARCH BY CITATION

References

  • 1
    Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia. a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 14560.
  • 2
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. 2): II37-II42.
  • 3
    Talley NJ. Review article. Functional dyspepsia – Should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 10715.
  • 4
    Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs 1993; 45: 91830.
  • 5
    Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 1986; 91: 14956.
  • 6
    Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind randomised placebo-controlled trials. Aliment Pharmacol Ther 1998; 12: 105565.
  • 7
    Finney JS, Kinnersley N, Hughes M, O'Bryan-Tear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 31220.
  • 8
    Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 16977.
  • 9
    Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 68996.
  • 10
    Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 134: 3619.
  • 11
    Kirchhoff R, Beckers C, Kirchhoff G, Trinczek-Gärtner H, Petrowicz O, Reimann H. Increase in choleresis by means of artichoke extract. Results of a randomized placebo-controlled double blind study. Phytomedicine 1994; 1: 10715.
  • 12
    Gebhardt R, Fausel M. Antioxidant and hepatoprotective effects of artichoke extracts and constituents in cultured rat hepatocytes. Toxicol Vitro 1997 ;11: 66972.
  • 13
    Gebhardt R. Inhibition of hepatic cholesterol biosynthesis by artichoke leaf extracts is mainly due to luteolin. Cell Biol Toxicol 1997; 13: 58.
  • 14
    Brown JE, Rice-Evans CA. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Rad Res 1998; 29: 24755.
  • 15
    Pérez-Garcia F, Adzet T, Canigueral S. Activity of artichoke leaf extract on reactive oxygen species in human leukocytes. Free Rad Res 2000; 33: 6615.
  • 16
    Rechner AR, Pannala AS, Rice-Evans CA. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Rad Res 2001; 35: 195202.
  • 17
    Fintelmann V. Langzeitanwendung eines Artischocken-Extraktes bei dyspeptischem Symptomkomplex. Ergebnisse einer Beobachtungsstudie. Naturamed 1998; 13: 1726.
  • 18
    Marakis G, Walker AF, Middleton RW, Booth JCL, Wright J, Pike D. Artichoke leaf extract reduces mild dyspepsia in an open study. Phytomedicine 2002; 9: 66499.
  • 19
    Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther 2001; 15: 20716.
  • 20
    Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999; 13: 22535.
  • 21
    Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJIII. Assessment of functional gastrointestinal disease: The bowel disease questionnaire. Mayo Clin Proc 1990; 65: 145679.
  • 22
    Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994; 39: 10908.
  • 23
    Van Zanten SJOV, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 66073.